Published September 17, 2024
0 views Journal article Open Access Open Access

Exploring Kleefstra syndrome cohort phenotype characteristics: Prevalence insights from caregiver-reported outcomes.

  • 1. International Research Centre on Artificial Intelligence (IRCAI) under the auspices of UNESCO, Jožef Stefan Institute, Ljubljana, Slovenia; IDefine Europe, Slovenia. Electronic address: tanja.zdolsek@ijs.si.
  • 2. Department of Human Genetics, Radboud university medical center, Nijmegen, the Netherlands; Donders Institute for Brain, Cognition and Behaviour, Radboud university medical center, Nijmegen, the Netherlands.
  • 3. Department for artificial Intelligence, Jožef Stefan Institute, Ljubljana, Slovenia.
  • 4. Institute of Genetics and Molecular and Cellular Biology (IGBMC), Université de Strasbourg, Illkirch, France.
  • 5. University of Strasbourg
  • 6. Institute of Genetics and Molecular and Cellular Biology (IGBMC), Université de Strasbourg, Illkirch, France; Tumor Biomechanics Lab, University of Strasbourg, Fédération de Médecine Translationnelle de Strasbourg (FMTS), Strasbourg, France.
  • 7. Department of Human Genetics, Radboud university medical center, Nijmegen, the Netherlands; Department of Clinical Genetics, Erasmus MC, Rotterdam, the Netherlands; Center of Excellence for Neuropsychiatry, Vincent van Gogh Institute for Psychiatry, Venray, the Netherlands.

Description

Kleefstra syndrome (KLEFS1) is a rare genetic neurodevelopmental disorder affecting multiple body systems. It continues to be under-researched, and its prevalence remains unknown. This paper builds on the international KLEFS1 cohort of 172 individuals based on the caregiver-reported outcomes collected within the online data collection platform GenIDA and reports the occurrence, frequency and severity of symptoms in KLEFS1. The study clearly shows the importance of caregiver-reported outcomes collections in the rare disease domain. Moreover, the study emphasizes the need for more specific and enhanced data collection methods, suggesting recommendations to optimize caregiver-reported registries and foster an even more profound understanding of rare diseases.
Enabled by The Lens

Open Access

Licence Attribution (CC BY-NC-ND)
Publisher Website Access full text